Jeff Willis

Company: Genentech

Job title: Senior Medical Director

Seminars:

Panel Discussion & Presentation: The Future Landscape of Dry-AMD Therapies 3:30 pm

Further analysis of the treatment landscape for Dry-AMD/GA – What’s on the horizon? Examine patient treatment journey with the emerging new treatment landscape Examine how clinicians/developers can support and deal with treatment burden Explore clinical trial development and the continued impact of the pandemic on on-going clinical trialsRead more

day: Day Two

Spotlight on GR39821- Phase 1 Single & Multiple-Dose Safety Study of Anti-High Temperature Requirement A1 (HtrA1) in GA 2:00 pm

Therapeutic Hypothesis for Targeting HtrA1 Review of GR39821 Phase 1 open-label, multicenter, single-and multiple-dose study of anti-HtrA1 in patients with GA secondary to AMD Review ocular specific enzyme activity-based antiHtra1 PD assayRead more

day: Track 1 Day 2 PM